Sangamo Therapeutics
SGMO
#8725
Rank
โ‚น14.99 B
Marketcap
โ‚น44.55
Share price
-6.45%
Change (1 day)
-73.30%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น0.56 Billion

According to Sangamo Therapeutics 's latest financial reports the company has โ‚น0.56 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น1.95 B-71.69%
2023-12-31$โ‚น6.90 B-71.73%
2022-12-31$โ‚น24.40 B-12.63%
2021-12-31$โ‚น27.93 B-23.2%
2020-12-31$โ‚น36.37 B17.87%
2019-12-31$โ‚น30.85 B20.17%
2018-12-31$โ‚น25.67 B114.04%
2017-12-31$โ‚น11.99 B29.63%
2016-12-31$โ‚น9.25 B-27.63%
2015-12-31$โ‚น12.78 B-2.35%
2014-12-31$โ‚น13.09 B74.17%
2013-12-31$โ‚น7.51 B111.62%
2012-12-31$โ‚น3.55 B-16.18%
2011-12-31$โ‚น4.23 B69.21%
2010-12-31$โ‚น2.50 B-24.78%
2009-12-31$โ‚น3.33 B25.09%
2008-12-31$โ‚น2.66 B-5.93%
2007-12-31$โ‚น2.83 B31.21%
2006-12-31$โ‚น2.15 B26.77%
2005-12-31$โ‚น1.70 B21.36%
2004-12-31$โ‚น1.40 B-31.04%
2003-12-31$โ‚น2.03 B-21.83%
2002-12-31$โ‚น2.60 B-34.53%
2001-12-31$โ‚น3.97 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
โ‚น1.927 T 343,580.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น21.01 B 3,646.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น864.13 B 153,976.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.635 T 291,546.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น1.712 T 305,266.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น7.121 T 1,269,754.24%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น544.11 B 96,916.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น4.663 T 831,343.22%๐Ÿ‡บ๐Ÿ‡ธ USA